An intensive three-drug regimen of heart medications did not significantly impact the rate of serious cardiovascular events ...

A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor's antiplatelet effects in patients undergoing urgent surgery or experiencing major ...